Great Point Partners’s ChemoCentryx CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-253,230
Closed -$13.9M – 46
2020
Q3
$13.9M Buy
+253,230
New +$13.6M 1.25% 20
2020
Q2
– Sell
-357,379
Closed -$14.4M – 43
2020
Q1
$14.4M Buy
+357,379
New +$15.2M 1.5% 21
2014
Q4
– Sell
-483,741
Closed -$2.18M – 40
2014
Q3
$2.18M Buy
+483,741
New +$2.56M 0.94% 28
2014
Q2
– Sell
-249,700
Closed -$1.66M – 45
2014
Q1
$1.66M Sell
249,700
-750,300
-75% -$5.21M 0.86% 30
2013
Q4
$5.79M Buy
+1,000,000
New +$5.16M 4.09% 8

Other funds holding CCXI

Great Point Partners's CCXI Position: Q4 2020 in Review

Great Point Partners sold out of ChemoCentryx (CCXI) in Q4 2020, closing a stake of 253,230 shares — an estimated $13.9M sold.

Great Point Partners first reported a position in CCXI in Q4 2013 and held it in 5 quarters. The position peaked at $14.4M in Q1 2020. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

  • Great Point Partners reported no remaining ChemoCentryx position as of Q4 2020 after selling out during the quarter.
  • Great Point Partners sold 253,230 ChemoCentryx shares in Q4 2020, an estimated $13.9M.
  • Great Point Partners first reported a position in ChemoCentryx in Q4 2013 and held it in 5 quarters.
  • Great Point Partners's ChemoCentryx position peaked at $14.4M in Q1 2020.
  • 196 funds tracked by Wall St. Rank held ChemoCentryx as of Q4 2020.

Based on Great Point Partners's 13F filing for Q4 2020, filed 16 Feb 2021.